Still, AST and ALT have been used as noninvasive surrogate markers of liver damage in epidemiological studies [25, 26] and the serum AST-to-ALT ratio is independently associated with metabolic syndrome and its components, consistent with the results of other studies in people of different ethnic origins [23, 27]. Here, GPT is linked to metabolic syndrome.